References
- The Expert Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J Am Med Assoc 1993; 269: 3015–23
- Granfone A, Campos H, McNamara J R. Effects of oestrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal dyslipidemic women. Metabolism 1992; 41: 1193–8
- Tonstad S, Ose L, Gorbitz C, Djoseland O, Bard J M, Fruchart J C. Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women. J Int Med 1995; 238: 39–47
- Darling G M, Johns J A, McCloud P I, Davis S R. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med 1997; 337: 595–601
- Shrapnel W S, Calvert G D, Nestel P J, Trustwell A S. Diet and coronary heart disease - a position statement of the National Heart Foundation of Australia. Med J Aust 1992; 156(Suppl)S9–16
- Davidson M H, Testolin L M, Maki K C, von Duvillard S, Drennan K B. A comparison of estogen replacement, pravastatin, and combined treatment for the management of hyper-cholesterolemia in postmenopausal women. Arch Intern Med 1997; 157: 1186–92
- Wakatsuki A, Ikenoue N M, Izumiya C, Okatani Y, Sagara Y. Effect of estrogen and simvastatin on low-density lipoprotein subclasses in hypercholesterolemic postmenopausal women. Obstet Gynecol 1998; 92: 367–72
- Koh K K, Cardillo C, Bui M N, et al. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation 1999; 99: 354–60
- Kovanen P T, Bilheimer D W, Goldstein J L, Jaramillo J J, Brown M S. Regulatory role for hepatic low density lipoprotein receptors in vitro in the dog. Proc Natl Acad Sci USA 1981; 78: 1194–8
- Grundy S M, Bilheimer D W. Inhibition of 3-hydroxy-3methylglutaryl-CoA reductase by mevinolin in familiar hypercholesterolemia heterozygotes: effects on cholesterol balance. Proc Natl Acad Sci USA 1984; 81: 2538–42
- Berr F, Eckel R H, Kern F, Jr. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women. J Lipid Res 1986; 27: 645–51
- Everson G T, McKinley C, Kern F, Jr. Mechanisms of gallstone formation in women. J Clin Invest 1991; 87: 237–46
- Brown M S, Goldstein J L. Lipoprotein receptors in the liver. J Clin Invest 1983; 72: 743–7
- Nair D R, Papadakis J A, Jagroop I A, Mikhailidis D P, Winder A F. Statins and fibrinogen. Lancet 1998; 351: 1430–2
- Sacks F M, Pfeiffer M A, Lemuel A M. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001–9
- Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9
- Dahlen G H, Guyton J R, Attar M, Farmer J A, Kautz J A, Gotto A M. Association of levels of Lp(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–62
- Cremer P, Nagel D, Labrot B, et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994; 24: 444–53
- Coleman M P, Key T JA, Wang D Y, et al. A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. Atherosclerosis 1992; 92: 177–85
- Hulley S, Grady D, Bush T, et al. HERS Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc 1998; 280: 605–12